DAPGM.E — Dap Gayrimenkul Gelistirme Balance Sheet
0.000.00%
- TRY6.17bn
- TRY7.44bn
- TRY8.01bn
Annual balance sheet for Dap Gayrimenkul Gelistirme, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | R2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 139 | 199 | 1,928 | 2,189 | 1,409 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 431 | 2,739 | 6,711 | 7,469 | 5,189 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 818 | 3,488 | 9,900 | 12,007 | 11,138 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5.67 | 194 | 288 | 101 | 75.4 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,634 | 12,050 | 22,126 | 29,992 | 31,456 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 516 | 3,080 | 5,329 | 6,260 | 4,913 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,896 | 8,035 | 12,522 | 16,347 | 16,779 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 738 | 4,015 | 9,604 | 13,644 | 14,678 |
| Total Liabilities & Shareholders' Equity | 2,634 | 12,050 | 22,126 | 29,992 | 31,456 |
| Total Common Shares Outstanding |